Gleixner, K. V., Mayerhofer, M., Sonneck, K., Gruze, A., Samorapoompichit, P., Baumgartner, C., Lee, F. Y., Aichberger, K. J., Manley, P. W., Fabbro, D., Pickl, W. F., Sillaber, C. and Valent, P. (2007) “Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT”, Haematologica. Pavia, Italy, 92(11), pp. 1451-1459. doi: 10.3324/haematol.11339.